Parkinson's Disease G2019S LRRK2 Genetic Testing Program

NCT04919356 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 836

Last updated 2023-01-18

No results posted yet for this study

Summary

Increase awareness of the G2019S LRRK2 mutation in Parkinson's and no cost genetic testing program.

Conditions

Interventions

GENETIC

G2019S LRRK2

No cost genetic testing for G2019S LRRK2

Sponsors & Collaborators

  • Engage Health Inc.

    collaborator INDUSTRY
  • Sano

    collaborator OTHER
  • Escape Bio, Inc.

    lead INDUSTRY

Principal Investigators

  • Carrolee Barlow, MD, PhD · ESCAPE Bio

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-08
Primary Completion
2022-12-05
Completion
2022-12-05

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04919356 on ClinicalTrials.gov